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HIV-1 Tat Stimulates Transcription Complex
Assembly through Recruitment of TBP
in the Absence of TAFs
Tamal Raha[, S. W. Grace Cheng[, Michael R. Green*
Howard Hughes Medical Institute, Programs in Gene Function and Expression and Molecular Medicine, University of Massachusetts Medical School, Worcester,
Massachusetts, United States of America
The human immunodeficiency virus type I (HIV-1) transactivator protein Tat is an unusual transcriptional activator that
is thought to act solely by promoting RNA polymerase II processivity. Here we study the mechanism of Tat action by
analyzing transcription complex (TC) assembly in vivo using chromatin immunoprecipitation assays. We find,
unexpectedly, that like typical activators Tat dramatically stimulates TC assembly. Surprisingly, however, the TC
formed on the HIV-1 long terminal repeat is atypical and contains TATA-box-binding protein (TBP) but not TBP-
associated factors (TAFs). Tat function involves direct interaction with the cellular cofactor positive transcription
elongation factor b (P-TEFb). Artificial tethering of P-TEFb subunits to HIV-1 promoter DNA or nascent RNA indicates
that P-TEFb is responsible for directing assembly of a TC containing TBP but not TAFs. On the basis of this finding, we
identify P-TEFb-dependent cellular promoters that also recruit TBP in the absence of TAFs. Thus, in mammalian cells
transcription of protein-coding genes involves alternative TCs that differ by the presence or absence of TAFs.
Citation: Raha T, Cheng SWG, Green MR (2005) HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs. PLoS Biol 3(2): e44.
Introduction
In eukaryotes, gene regulation is largely controlled at the
transcriptional level. Factors involved in the accurate tran-
scription of eukaryotic structural genes by RNA polymerase II
(class II genes) can be classiﬁed into two groups. First, general
(or basic) transcription factors (GTFs) are necessary and can
be sufﬁcient for accurate transcription initiation in vitro (for
review, see [1]). Such factors include RNA polymerase II itself
and at least six GTFs: TFIID, TFIIA, TFIIB, TFIIE, TFIIF, and
TFIIH. The GTFs assemble on the core promoter in an
ordered fashion to form a transcription pre-initiation
complex (PIC). The ﬁrst step in PIC assembly is binding of
the GTF TFIID to the TATA box. TFIID is a multi-subunit
complex consisting of the TATA-box-binding protein (TBP)
and a set of tightly bound TBP-associated factors (TAFs)
[2,3,4].
Transcriptional activity is greatly stimulated by the second
class of factors, promoter-speciﬁc activator proteins (activa-
tors). In general, cellular activators are sequence-speciﬁc
DNA-binding proteins whose recognition sites are usually
present in sequences upstream of the core promoter
(reviewed in [5,6]). In addition to a sequence-speciﬁc DNA-
binding domain, a typical activator also contains a separable
activation domain. A variety of studies indicate that
activators work, at least in part, by increasing PIC formation
through a mechanism thought to involve direct interactions
with one or more components of the transcription machinery
[1,7,8,9]. Activators can also act through other mechanisms,
such as increasing the rate of transcriptional elongation,
promoting multiple rounds of transcription, and directing
chromatin modiﬁcations (reviewed in [10]).
The Tat protein of human immunodeﬁciency virus type I
(HIV-1) is a potent activator of the viral long terminal repeat
(LTR) and is required for viral replication (reviewed in
[11,12,13]). Unlike typical activators, which bind to promoter
DNA, Tat binds to nascent viral RNA through an RNA-
binding site termed the TAR element. Tat function involves
direct interaction with the cellular cofactor called positive
transcription elongation factor b (P-TEFb), which is com-
posed of two subunits, cyclin T1 (CycT1) and CDK9 (reviewed
in [14,15]). Several lines of evidence have suggested that
unlike typical activators, Tat stimulates transcriptional
elongation rather than initiation. According to the current
model (reviewed in [11,12,13]), in the absence of Tat, RNA
polymerase II initiates from the HIV-1 LTR in a form unable
to elongate efﬁciently and thus stalls (or pauses) near the
transcription start site. When present, Tat binds to TAR and
recruits P-TEFb, allowing CDK9 to phosphorylate the C-
terminal domain of the RNA polymerase II large subunit,
thereby increasing transcriptional processivity.
The chromatin immunoprecipitation (ChIP) assay has
provided a powerful approach to study in vivo the mecha-
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nism by which activators stimulate transcription and to
delineate the composition of transcription complexes (TCs).
In yeast, ChIP analysis has been used to show that activators
function, at least in part, by stimulating TC assembly. These
studies have also revealed that at certain promoters TBP is
recruited in the absence of TAFs [16,17], indicating that, at
least in yeast, some TCs contain TBP but not TFIID. Here we
perform ChIP experiments to study the mechanism of
transcription activation by Tat in vivo.
Results
Experimental Design
To analyze transcription stimulation by Tat and other
activators we performed ChIP experiments in transiently
transfected mammalian tissue culture cells. Plasmids express-
ing a reporter construct, containing a core promoter and
various combinations of activator-binding sites, were tran-
siently transfected into HeLa or 293T cells. In some experi-
ments, a second plasmid expressing an activator was co-
transfected. Reporter activity or primer extension was used
to quantitate transcription levels. TC assembly was analyzed
by a ChIP assay using antibodies directed against components
of four representative GTFs involved in distinct stages of TC
assembly: TFIID (TBP and typically TAF1 and TAF5), TFIIB,
mediator (CDK8 and hMed6), and RNA polymerase II (RBP1).
In most experiments the analysis was performed using two
sets of primers: one set encompassed the core promoter,
transcription start site, and immediate downstream region,
and a second set was located far downstream of the
transcription start site, within the open reading frame (ORF).
Diverse Activators Function by Increasing TC Assembly
In yeast, it has been shown that activators stimulate TC
assembly, which is evident at the earliest step of this process,
interaction of TBP with the TATA box [18,19]. To conﬁrm
that this was also the case in mammalian cells, we used a ChIP
assay to analyze TC assembly in three well-characterized
model systems: transcription directed by Gal4-VP16, tran-
scription directed by the SV40 enhancer, and transcription
directed by the adenovirus (Ad) E1a protein.
The artiﬁcial activator Gal4-VP16 contains an unusually
potent acidic activation domain and can stimulate tran-
scription in many species and cell types including mammalian
tissue culture cells [5]. Figure 1A shows, consistent with
previous studies, that on a synthetic promoter containing
four Gal4-binding sites upstream of the TATA box, tran-
scription was not detectable in the absence of Gal4-VP16,
whereas addition of Gal4-VP16 led to a large transcriptional
increase. The accompanying ChIP assay shows that in the
absence of Gal4-VP16 there was no detectable association of
GTFs with the promoter. However, addition of Gal4-VP16 led
to a large increase in recruitment of all GTFs analyzed,
explaining the transcriptional stimulation. Consistent with
the transcription results, RNA polymerase II was associated
with the ORF in the presence but not absence of Gal4-VP16.
Also, as expected, the GTFs were associated with the core
promoter and not the ORF.
Transcription of certain genes requires a cis-acting
enhancer element that is often located at a distance from
the transcription start site (reviewed in [20]). The enhancer
functions by providing binding sites for cellular activators.
For example, a minimal b-globin promoter is inefﬁciently
expressed, but addition of an appropriate enhancer element
dramatically increases transcription [21]. Figure 1B shows, as
expected, that a minimal rabbit b-globin promoter was
virtually inactive, whereas transcriptional activity was greatly
increased by addition of the SV40 enhancer. The ChIP
analysis shows that in the absence of the SV40 enhancer there
was no detectable association of GTFs with the b-globin
promoter. Upon addition of the SV40 enhancer, there was a
large increase in GTF recruitment that correlated with the
increased transcriptional activity.
Finally, we analyzed transcription directed by the Ad E1a
protein. Efﬁcient transcription from Ad early promoters
requires the viral E1a protein as well as the participation of
cellular transcription factors that also bind to the promoter
(reviewed in [22]). For example, the Ad E4 promoter contains
multiple binding sites for cellular ATF proteins, which are
required for efﬁcient transcription activation by E1a [23].
Figure 1C shows, as expected, that in the absence of E1a there
was only a background level of Ad E4 transcription, and that
E1a increased transcription dramatically. The accompanying
ChIP assay shows that in the absence of E1a there was no
signiﬁcant association of GTFs with the promoter, whereas
transfection of E1a resulted in recruitment of all GTFs
analyzed in a manner that paralleled the increased transcrip-
tional activity.
In summary, the results of Figure 1 indicate, as in yeast, that
in three well-studied higher eukaryotic examples, transcrip-
tion activation involves promotion of TC assembly. Moreover,
as in yeast, the stimulatory effect is evident at the earliest step
of TC assembly, the TBP–TATA box interaction.
The HIV-1 Tat Protein Stimulates TC Assembly through
Recruitment of TBP in the Absence of TAFs
We next investigated Tat-mediated transcription activation
and TC assembly on the HIV-1 LTR promoter. Figure 2A
shows, as expected, that in the absence of Tat there was no
detectable transcription from the HIV-1 LTR, and that
addition of Tat increased transcription dramatically. The
accompanying ChIP experiment (Figure 2A, left) shows that
in the absence of Tat, association of GTFs with the core
promoter was virtually undetectable. Sp1, a constitutive
cellular activator that binds upstream of the HIV-1 core
promoter was, as expected, associated with the promoter in
the absence of Tat and unaffected by Tat addition (Figure 2A,
right). Signiﬁcantly, in the absence of Tat there was no
detectable association of RNA polymerase II near the tran-
scription start site or within the ORF (Figure 2A, left).
However, following addition of Tat, there was a large increase
in association of TBP, TFIIB, mediator, and RNA polymerase
II with the promoter, which paralleled the transcriptional
increase. Also, as expected, there was a large increase in
association of RNA polymerase II with the ORF. Following
recruitment of P-TEFb to the HIV-1 LTR by Tat, P-TEFb
associates with and phosphorylates RNA polymerase II
[12,24]. Accordingly, the ChIP assay (Figure 2A, right) shows
that in the presence of Tat the two P-TEFb subunits, CycT1
and CDK9, were present at both the promoter and the ORF.
Unexpectedly, although TBP and the other GTFs were
efﬁciently recruited to the promoter in the presence of Tat,
there was no signiﬁcant recruitment of the two TAFs
analyzed, TAF1 or TAF5 (left panel).
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Figure 1. Diverse Activators Function by Increasing TC Assembly
(A) Gal4-VP16. Left: a CAT reporter construct containing the E1b core promoter and four Gal4-binding sites (G4E1bCAT) was transiently trans-
fected into 293T cells, together with a plasmid expressing Gal4-VP16. Middle: transcription levels were determined by quantitating CAT reporter
activity. Right: TC assembly was analyzed by a ChIP assay using the indicated antibodies. The percentage of DNA immunoprecipitated relative to
input is indicated.The locationof theprimersused in theChIP assay to analyze thepromoter (black) orORF (gray) is schematically shownon the left.
(B) SV40 enhancer. Shown on the left is a schematic diagram of a construct containing a minimal rabbit b-globin promoter and harboring or
lacking the SV40 enhancer. Also shown is transcription analysis by CAT assay (middle) andTC assembly (right) in transiently transfectedHeLa cells.
(C) Ad E1a. Left: a CAT reporter construct containing the Ad E4 promoter and upstream ATF-binding sites (E4CAT) was transiently transfected
into HeLa cells, together with a plasmid expressing Ad E1a. Middle: transcription analysis by CAT assay is shown. Right: TC assembly is shown.
DOI: 10.1371/journal.pbio.0030044.g001
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We note that recruitment of Tat was not observed in the
ChIP assay, which detects proteins bound either directly or
indirectly to DNA (reviewed in [25]). Unlike all the other
transcription factors, which associate with the TC through
DNA–protein or protein–protein interactions, Tat is bound
to nascent RNA [11,12,13].
To determine whether the lack of TAF recruitment was a
general feature of Tat-directed transcription, we analyzed a
chronically HIV-1-infected cell line, 8E5/LAV, which harbors
an integrated provirus that is constitutively transcribed [26].
Figure 2B shows that TBP, TFIIB, mediator, Sp1, P-TEFb, and
RNA polymerase II, but not TAF1 or TAF5, were associated
with the integrated proviral promoter, consistent with the
results of the transient transfection assay.
We also analyzed a second chronically HIV-1-infected cell
line, U1, which has been used as a model to study viral
latency. U1 cells harbor an integrated viral genome, but,
unlike 8E5/LAV cells, the constitutive level of viral expression
is extremely low. Viral expression can be induced by phorbol
esters, which stimulate transcription through upstream NF-
jB-binding sites in the HIV-1 LTR, leading to Tat synthesis
and a subsequent substantial Tat-mediated transcriptional
Figure 2. The HIV-1 Tat Protein Stimulates TC Assembly through Recruitment of TBP in the Absence of TAFs
(A) A CAT reporter construct containing the TAR element and Sp1-binding sites ([83]HIV LTRCAT) was transiently transfected into 293T cells,
together with a plasmid expressing Tat. Left: transcription analysis by CAT assay is shown. Middle and right: TC assembly is shown. Bottom: a
schematic diagram of the CAT reporter construct is shown.
(B) TC assembly was monitored in a chronically HIV-1-infected cell line, 8E5/LAV, that harbors an integrated provirus that is constitutively
transcribed. Virus production was conﬁrmed by analysis of p24 levels and reverse transcriptase activity in the culture medium (data not shown).
(C) TC assembly was monitored in the chronically infected cell line U1 on the integrated HIV-1 LTR in the presence or absence of PMA.
DOI: 10.1371/journal.pbio.0030044.g002
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increase [27,28]. Thus, U1 cells provide an experimental
system to analyze TC assembly from an integrated HIV-1 LTR
in the inactive (PMA) or active (þPMA) state. Figure 2C
shows that following activation of the HIV-1 LTR by PMA
addition, there was a large increase in recruitment of TBP
and RNA polymerase II, whereas TAF1 and TAF5 were once
again not detected.
To investigate further the composition of the TC formed
on the HIV-1 LTR, we obtained a panel of antibodies directed
against nine additional human TAFs (TAF2, TAF4, TAF6,
TAF7, TAF8, TAF9, TAF11, TAF12, and TAF13), as well as
antibodies against four subunits of the STAGA complex
(PAF65b, hSpt3, hGCN5, and TRRAP) and the TBP-interact-
ing protein Mot1. The results (Figure 3A) show that when
transcription was directed by Gal4-VP16, all 11 TAFs
analyzed were bound to the promoter, as expected for
recruitment of TFIID. By contrast, when transcription was
directed by Tat, none of the 11 TAFs were recruited to the
Figure 3. TAFs Are Not Recruited to the HIV 1-LTR and Not Required by Tat for Transcription Activation
(A) TC assembly was analyzed by a ChIP assay using antibodies directed against nine additional human TAFs, four subunits of the STAGA
complex, and Mot1. TAFs that are also present in STAGA are indicated by asterisks. Bottom: schematic diagrams of the promoter constructs are
shown.
(B) Transcription analysis in ts13 cells, which harbor a temperature-sensitive mutation in TAF1. Ts13 cells grown at the permissive or non-
permissive temperature were transiently transfected with a luciferase reporter plasmid and a plasmid expressing a transcriptional activator.
Transcription was monitored by luciferase activity, and normalized relative to activity at the permissive temperature.
(C) Left: immunoblot analysis is shown. 293A cells were transfected with a TAF5 or TAF12 shRNA expression vector or an empty vector (control)
and analyzed by immunoblotting using the indicated antibodies. Right: transcription levels were monitored by luciferase reporter activity in
shRNA-treated cells, and normalized relative to luciferase activity in non-shRNA-treated cells.
DOI: 10.1371/journal.pbio.0030044.g003
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HIV-1 LTR. Gal4-VP16 also recruited all four STAGA
subunits analyzed, none of which were associated with the
HIV-1 LTR in the presence of Tat. Finally, Mot1 was not
recruited when transcription was directed by either Gal4-
VP16 or Tat. On the basis of these data we conclude that the
TC formed on the HIV-1 LTR lacks at least 11, and probably
all, of the 14 TFIID TAFs. In the experiments presented
below, TAF1 and TAF5 were analyzed as representative TAFs.
TAFs Are Not Required for Tat-Mediated Transcription
Activation
The results of the ChIP experiments strongly suggested that
transcription activation by Tat did not require TAFs. To
conﬁrm this supposition, we examined the ability of Tat to
stimulate transcription following TAF inactivation. First, we
examined the ability of Tat to activate transcription in ts13
cells, which harbor a temperature-sensitive mutation in TAF1
[29,30]. Figure 3B shows, as expected, that inactivation of
TAF1 signiﬁcantly diminished transcription activation by
VP16 and E1a, whereas Tat-mediated transcription activation
was unaffected. In a second approach, we used short hairpin
RNAs (shRNAs) to knockdown expression of TAF5 or TAF12
in 293A cells. Immunoblot analysis conﬁrmed that shRNA-
mediated knockdown of TAF expression was efﬁcient and
speciﬁc (Figure 3C, left). Transcriptional analysis revealed
that knockdown of TAF5 or TAF12 substantially decreased
transcription directed by VP16, whereas Tat-mediated tran-
scription activation was unaffected (Figure 3C, right).
(Because 293A cells are transformed by and express E1a,
activation by E1a could not be analyzed in this experiment.)
Collectively, the results of Figure 3 demonstrate that TAFs are
not involved in transcription activation directed by the HIV-1
Tat protein.
Tat and P-TEFb Direct Recruitment of TBP in the Absence
of TAFs
The results described above indicate that on the HIV-1
LTR transcription activation involves assembly of an atypical
TC that contains TBP but not TAFs. However, these experi-
ments do not distinguish whether the critical determinant for
recruitment of TBP and not TFIID is Tat or the promoter, the
HIV-1 LTR. To address this issue we performed a series of
artiﬁcial tethering experiments.
Previous studies have shown that Tat can activate tran-
scription when directed to the HIV-1 LTR through a
heterologous DNA-binding domain [31,32,33]. We analyzed
TC assembly using an HIV-1 LTR derivative that lacked the
TAR element and contained upstream Gal4-binding sites. We
ﬁrst examined the TCs formed on this promoter by three
Gal4 fusion proteins: Gal4-VP16, Gal4-E1a, and Gal4-Tat.
Consistent with previous studies [32], Figure 4 shows that all
three Gal4 fusion proteins activated transcription from this
modiﬁed HIV-1 LTR derivative. The accompanying ChIP
experiments show that Gal4-VP16 and Gal4-E1a supported
Figure 4. Tat and P-TEFb Direct Recruitment of TBP in the Absence of TAFs When Tethered to DNA
Transcription (left) and TC assembly (right) were examined using an HIV-1 LTR derivative that lacks the TAR element and contains upstream
Gal4-binding sites (G6[83]HIV LTRDTARCAT; bottom) and a series of Gal4 fusion proteins, as indicated.
DOI: 10.1371/journal.pbio.0030044.g004
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assembly of a TC that contained all of the GTFs, including
TAF1 and TAF5. By contrast, Gal4-Tat directed assembly of a
TC in which the TAFs were present at a level signiﬁcantly
below that of TBP and other GTFs. These results indicate
that the activator Tat, and not the HIV-1 LTR promoter,
directs the selective recruitment of TBP in the absence of
TAFs.
As discussed above, Tat interacts directly with CycT1, a
subunit of the transcription elongation factor P-TEFb. Thus,
Tat is an adaptor whose function is to recruit P-TEFb. We
therefore considered that P-TEFb was ultimately responsible
for the selective recruitment of TBP in the absence of TAFs.
To address this possibility, we analyzed transcription activa-
tion by the two P-TEFb subunits, CycT1 and CDK9.
Consistent with previous results [34,35], both Gal4-CycT1
and Gal4-CDK9 activated transcription. The ChIP analysis
indicates that both Gal4-CycT1 and Gal4-CDK9 stimulated
assembly of a TC that contained all of the GTFs but lacked
TAF1 and TAF5. These results conﬁrm that P-TEFb is
responsible for directing selective recruitment of TBP in
the absence of TAFs.
In the experiments shown in Figure 4, P-TEFb was tethered
to DNA, whereas on the HIV-1 LTR, P-TEFb is normally
bound through Tat to nascent RNA. We therefore sought to
verify that P-TEFb, when bound to nascent RNA, would also
selectively recruit TBP in the absence of TAFs. Previous
studies have shown that recruitment of CycT1/P-TEFb to the
HIV-1 LTR through a heterologous RNA-binding domain can
activate transcription in the absence of Tat [36]. We therefore
asked whether such an artiﬁcially recruited CycT1/P-TEFb
protein would stimulate assembly of a TC that contained TBP
but not TAFs. We used a previously characterized HIV-1 LTR
derivative [36] in which the TAR element was replaced by a
minimal binding site for the HIV-1 Rev protein, and
examined the ability of a Rev-Tat or Rev-CycT1 fusion
protein to stimulate TC assembly.
Figure 5 shows that in the absence of a Rev fusion protein,
both transcription and GTF recruitment were virtually
undetectable. Addition of Rev-Tat or Rev-CycT1 resulted in
a large transcriptional increase, as expected from previous
studies. Signiﬁcantly, addition of Rev-Tat or Rev-CycT1 also
led to a large increase in recruitment of TBP, TFIIB,
mediator, and RNA polymerase II, but not TAF1 or TAF5.
Thus, in the absence of Tat, Rev-CycT1 stimulated assembly
of a TC that contained TBP but not TAFs.
Figure 5. Tat and P-TEFb Direct Recruitment of TBP in the Absence of TAFs When Tethered to RNA
Transcription (left) and TC assembly (right) were examined using a Rev-Tat or Rev-CycT1 fusion protein and an HIV-1 LTR derivative in which
the TAR element was replaced by stem loop IIB (SLIIB), a Rev-protein-binding site (HIV SLIIBCAT; bottom).
DOI: 10.1371/journal.pbio.0030044.g005
Figure 6. The Cellular Activator CIITA Directs Recruitment of TBP in the
Absence of TAFs
TC assembly was monitored on the promoters of HLA-DM and HLA-
DR, two MHC class II genes known to use CIITA, and, as a negative
control, GAPDH.
DOI: 10.1371/journal.pbio.0030044.g006
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Identification of Cellular Promoters That Recruit TBP in the
Absence of TAFs
P-TEFb is also a cofactor for several cellular activators, the
best studied of which is CIITA, a transcription factor involved
in the expression of major histocompatibility complex (MHC)
class II genes (reviewed in [37]). In fact, overexpression of Tat
can inhibit transcription of MHC class II genes by competing
with CIITA for P-TEFb binding [38,39].
We therefore tested whether the promoters of MHC class II
genes also recruited an atypical TC that contained TBP but
not TAFs. We analyzed two MHC class II genes known to use
CIITA, HLA-DM and HLA-DR, and, as a negative control,
GAPDH. RT-PCR analysis conﬁrmed, as expected, that both
HLA-DM and HLA-DR were expressed in 293T cells (data not
shown). The associated ChIP experiment (Figure 6) shows that
the TCs formed on both HLA-DM and HLA-DR contained all
of the GTFs but lacked signiﬁcant levels of TAF1 and TAF5.
By contrast, the TC formed on GAPDH contained all of the
GTFs, including TAF1 and TAF5. These results indicate that
TBP, and not TFIID, is also selectively recruited to speciﬁc
cellular promoters and strongly support the conclusion that
P-TEFb directs this recruitment.
Discussion
A variety of studies have proposed that Tat promotes
transcriptional elongation [11,12,13]. However, the effect of
Tat on TC assembly in vivo has not been previously analyzed.
In this report, we studied the mechanism of Tat action using
ChIP assays and found, unexpectedly, that Tat dramatically
stimulates TC assembly on the HIV-1 LTR. Perhaps most
surprising, the HIV-1 LTR contains an atypical TC that lacks
TFIID and that has not been previously described in
mammalian cells. By contrast, transcription activation by
Gal4-VP16, the SV40 enhancer, or the Ad E1a protein
involves assembly of a TC that contains TFIID. Thus, our
results reveal mechanistic similarities between apparently
diverse classes of activators and unanticipated differences in
the composition of mammalian TCs.
In an HIV-1-infected cell, a low level of Tat-independent
transcription can be elicited by cellular activators, such as
Sp1, NF-jB, and NFAT, which are bound to upstream regions
of the HIV-1 LTR [12]. Tat is recruited to the vicinity of the
promoter by binding to this low level of nascent TAR RNA,
where it facilitates subsequent rounds of TC assembly and
transcription initiation. Thus, once a threshold level of
transcription is achieved, Tat stimulates additional tran-
scription, thereby increasing the number of Tat-binding sites
(reviewed in [40]). This positive feedback mechanism would
ensure that viral transcription rapidly increases or decreases,
which may be relevant to the ability of HIV-1 to enter latency
and, conversely, to be activated from the latent state.
Tat Stimulates TC Assembly
Previous studies have provided two principal lines of
evidence that Tat functions by stimulating transcription
elongation. First, Tat has been found to stimulate elongation
in an in vivo nuclear run-off assay [41,42,43,44], and in the
absence of Tat, apparent prematurely terminated transcripts
have been detected [41,45]. However, these in vivo results are
complicated by the presence of a second promoter, the
initiator of short transcripts, adjacent to the HIV-1 LTR
[46,47]. In our experiments RNA polymerase II was not
detected either near or far downstream of the transcription
start site in the absence of Tat and thus provided no evidence
for a paused (or stalled) RNA polymerase II. Consistent with
our ChIP data, nuclear run-off experiments have shown that
Tat increases the density of RNA polymerase II 9- to 15-fold
within the ﬁrst 25 nucleotides downstream of the tran-
scription start site [42,43], indicating that Tat also stimulates
initiation. A second line of evidence has been derived from in
vitro experiments in which Tat was found to enhance
elongation but not initiation (see, for example, [48]).
However, in vitro transcription experiments may fail to
faithfully recapitulate in vivo regulation: for example, under
in vitro conditions using naked DNA templates, PIC assembly
and initiation may no longer be rate-limiting on the HIV-1
LTR. Consistent with this possibility, the HIV-1 LTR is a
relatively strong promoter when analyzed as naked DNA in
vitro in the absence of Tat (see, for example, [49]). Moreover,
initiation effects would not be observed if the cell-free system
did not support multiple rounds of transcription from a
single DNA template (see, for example, [50]).
It is important to emphasize that our ChIP assay only
analyzed TC assembly. Thus, our results do not rule out the
possibility that in addition to stimulating TC assembly, Tat
also promotes transcription elongation. Based upon the
results presented here and previous studies (reviewed in
[11,12,13]), we believe that Tat stimulates TC assembly,
thereby promoting initiation and elongation. This dual
mechanism of action may explain why Tat is such a potent
activator of transcription.
Tat and P-TEFb Direct Recruitment of TBP in the Absence
of TAFs
We have shown that transcription from the HIV-1 LTR
involves TBP but not TFIID. This result was particularly
unexpected because in mammalian cells TBP is bound to
TAFs extremely tightly and numerous biochemical studies
have failed to ﬁnd free TBP [2,3,4]. None of the 11 TAFs, four
STAGA subunits, or Mot1 was present on the HIV-1 LTR,
strongly suggesting that free TBP is recruited. However, we
cannot exclude the possibility that TBP may be associated
with unknown proteins that remain to be identiﬁed.
Several considerations rule out the possibility that TFIID is
actually present in the TC directed by Tat/P-TEFb but that the
TAFs are not detected in the ChIP assay. First, numerous
studies have shownChIP to be a remarkably general and robust
assay that has successfully detected a wide variety of activators,
general initiation and elongation components, chromatin
remodeling factors, and histone variants. Second, in experi-
ments not involving Tat or P-TEFb, TAFs were detected at
levels comparable to that of TBP on ﬁve different promoters
(G4E1bCAT, b-globin, E4CAT, G6(83)HIV LTRDTARCAT,
and GAPDH). Third, when TC assembly was directed by Tat
or P-TEFb theChIP assay detected all GTFs analyzed, including
TBP, but not TAFs on six different promoters ([83]HIV
LTRCAT, integrated HIV-1/LAV, HIV SLIIBCAT, G6[83]HIV
LTRDTARCAT, HLA-DM, and HLA-DR]. Finally, and perhaps
most persuasively, on the same promoter the presence or
absence of TAFs as monitored by ChIP was dictated solely by
the upstream bound Gal4 fusion protein (see Figure 4).
Artiﬁcial tethering experiments clearly demonstrate that P-
TEFb directs recruitment of TBP in the absence of TAFs.
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Strongly supporting this conclusion is our identiﬁcation of
cellular promoters for which P-TEFb is a cofactor and whose
TC contains TBP but not TAFs. How P-TEFb selectively
recruits TBP and not TFIID remains to be determined. It has
been previously thought that P-TEFb is purely an elongation
factor [14,15]. However, we have shown that when tethered to
DNA or nascent RNA, P-TEFb can also stimulate TC assembly
and dictate the composition of the TC.
In yeast, promoters have been grouped into two extreme
classes based on their requirement for TAFs [16,17]. TAF-
dependent promoters require TAFs for transcription, and on
these promoters TBP and TAFs are present at comparable
levels. TAF-independent promoters do not require TAFs for
activity, and on these promoters TAFs are either absent or
present at levels far below that of TBP. These yeast results are
strikingly similar to the ﬁndings reported here, and taken
together these results indicate that in both yeast and
mammalian cells, transcription of protein-coding genes
involves alternative TCs that differ by the presence or
absence of TAFs.
Materials and Methods
Plasmids. To generate the G4E1bCAT construct, pDSG39, four
Gal4-binding sites were inserted upstream of the E1b TATA box and
the CAT ORF in the vector pSP72 (Promega, Madison, Wisconsin,
United States). The b-globin constructs containing (pBS) or lacking
(pB/E) the SV40 enhancer were provided by Walter Schaffner; pBS
contains a 196-bp SV40 enhancer–containing fragment inserted into
a plasmid derived from pB6 [51], which harbors the b-globin gene. The
E4CAT construct, pE4CAT, was previously described [52]. The pFR-
Luc plasmid, containing ﬁve Gal4-binding sites upstream of the E1b
TATA box and the luciferase reporter gene, was obtained from
Stratagene (La Jolla, California, United States). The HIV LTR-
luciferase construct was previously described [53]. The (83)HIV
LTRCAT and G6(83)HIV LTRDTARCAT constructs, were previously
described [54]. The HIV SLIIBCAT construct, pHIV/SLIIB/CAT [36],
was provided by Bryan Cullen.
Plasmids expressing the Gal4-VP16 fusion protein (pGal4-VP16;
[55]), E1a (pSV-E1a; [52]), Tat (CMV-Tat; [56]), and the Gal4-E1a
fusion protein (pGal4-E1a; [52]) were previously described. To
generate pGal4-Tat, pGal4-CycT1, and pGal4-CDK9, the full-length
Tat protein, the hCycT1-containing EcoR1 fragment from phCycT1-
Rev [36], or the CDK9-containing EcoR1 fragment from pSG5-CDK9
(a gift from Claude Gazin), respectively, were individually cloned into
plasmid pSG424 [55] as an in-frame fusion with the Gal4 DNA-
binding domain. Rev fusion-protein plasmids pTAT-Rev and
phCycT1-Rev [36] were obtained from Bryan Cullen.
Antibodies. The a-Gal4 mouse monoclonal (sc-510), a-CDK8 goat
polyclonal (sc-1521), a-CDK9 goat polyclonal (sc-7331), a-CycT1
goat polyclonal (sc-8127), a-Med6 goat polyclonal (sc-9434), a-
GCN5 goat polyclonal (sc-6303); a-TRRAP rabbit polyclonal (sc-
11411), a-TAF1 mouse monoclonal (sc-735), a-TAF5 mouse mono-
clonal (sc-743), a-Sp1 rabbit polyclonal (sc-59X), and a-alpha tubulin
mouse monoclonal (sc-5268) antibodies were obtained from Santa
Cruz Biotechnology (Santa Cruz, California, United States). The a-
RNA polymerase II mouse monoclonal antibody (8WG16) was
obtained from BAbCO (Berkeley, California, United States). The a-
Tat rabbit antiserum was obtained from the National Institutes of
Health AIDS Research and Reference Reagent Program (catalog
number 705; [57]). The a-TBP mouse monoclonal antibody (SL30–3-
563) was provided by Nouria Hernandez; the a-TAF2, a-TAF4, a-
TAF6, a-TAF7, a-TAF8, a-TAF9, a-TAF11, a-TAF12, a-TAF13, and a-
hSpt3 rabbit polyclonal antibodies were provided by Robert Roeder;
the a-Mot1 rabbit polyclonal antibody was provided by Franklin Pugh;
and the a-PAF65b rabbit polyclonal antibody was provided by
Yoshihiro Nakatani.
Transcription. Transcription was measured either by RT-PCR
analysis from total RNA isolated from transfected cells or by
chloramphenicol acetyl transferase (CAT) assay [58] using 14C
chloramphenicol followed by thin layer chromatography. Signals
were visualized by autoradiography and quantitated using National
Institutes of Health Image 1.62 software.
ChIP assay. HeLa and 293T cells were transfected with 10 lg of
effector plasmids and 5 lg of reporter plasmid using standard CaCl2
transfection methods [59]. Forty-eight hours after transfection, cells
were cross-linked by adding formaldehyde to the medium (1% ﬁnal
concentration) and incubated for 10 min at room temperature. The
cross-linking reaction was quenched by adding glycine to a ﬁnal
concentration of 0.125 M and incubating for an additional 10 min at
room temperature. Cells were then washed with ice-cold PBS
containing protease inhibitors, scraped in the same buffer, and
washed in PBS. Cells were then lysed in SDS-lysis buffer (1% SDS, 50
mM Tris-HCl [pH 8.0], 10 mM EDTA, and protease inhibitors), and
sonicated at least 6–8 times at output 8 for 10 s, with 2 min incubation
on ice in between. Lysates were centrifuged at 15,000 rpm for 15 min
at 4 8C; 5% of the lysates were kept as input. Lysates were diluted 10-
fold with ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM
EDTA, 16.7 mM Tris-HCl [pH 8.0], 16.7 mM NaCl, and protease
inhibitors) and pre-cleared with 80 ll of Protein A Agarose-50%
Slurry (Upstate Biotechnology, Lake Placid, New York, United States)
for 30 min at 4 8C with constant agitation. The agarose beads were
pelleted, and the supernatant was incubated overnight with the
primary antibody. To each tube, 50 ll of Salmon Sperm DNA/Protein
A Agarose-50% Slurry (Upstate Biotechnology) was added, and the
mixture was incubated for 1 h at 4 8C. The agarose beads were pelleted
by gentle centrifugation, the supernatant was removed, and the pellet
was washed twice with low-salt immune complex wash buffer (0.1%
SDS, 1%Triton X-100, 2 mMEDTA, 20 mMTris-HCl [pH 8.0], and 150
mM NaCl), once with high-salt immune complex wash buffer (0.1%
SDS, 1%Triton X-100, 2 mMEDTA, 20 mMTris-HCl [pH 8.0], and 500
mM NaCl), once with LiCl immune complex wash buffer (0.25 M LiCl,
1% NP40, 1% C24H39NaO4, 1 mM EDTA, and 10 mM Tris-HCl [pH
8.0]), and twice with TE (10 mM Tris-HCl [pH 8.0] and 1 mM EDTA).
Chromatin was eluted with freshly prepared elution buffer (1% SDS
and 0.1 M CHNaO3). After reversal of the cross-links, the samples were
treated with proteinase K for 1 h at 45 8C, extracted by phenol/
chloroform, and ethanol precipitated. The pellet was resuspended in
TE, and PCR was performed. Autoradiograms were scanned and
quantitated by the National Institutes of Health ImageJ program. IP
DNA was quantitated and presented as the ratio of IP to input. Primer
sequences are available upon request.
TAF inactivation. For TAF1 inactivation, ts13 cells [60] were
initially cultured at the permissive temperature (33 8C), after which
one set of 6-well plates was shifted to the non-permissive temperature
(39.5 8C) while another set was kept at 33 8C. Sixteen hours later, cells
were co-transfected with a plasmid expressing a transcriptional
activator (Gal4-VP16, E1a, or Tat) and a luciferase reporter plasmid,
and incubated further for 24 h prior to measuring transcription by
luciferase assay. For shRNA-mediated inactivation of TAFs, 293A cells
were transfected with either pcDNA3 (Invitrogen, Carlsbad, Califor-
nia, United States) or a TAF5 or TAF12 shRNA expression vector
(Open Biosystems, Huntsville, Alabama, United States), and 18 h later
were co-transfected with effector and reporter plasmids. Tran-
scription activation was monitored by luciferase activity 24 h
following transfection.
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